Christine Fox, EVP, Head of U.S. Commercial: Teva Pharmaceutical Industries TEVA Sell · Filed 25/11/24

Trade details

Type: Insider sale
Amount: $699,514.62
Shares · price: 28,229 sh · $24.78 a share
Held after: 63,647 sh
Stock: Teva Pharmaceutical Industries TEVA
Person: Christine FoxEVP, Head of U.S. Commercial
Trade date: 25/11/20
Filed: 25/11/24
Days to filing: 4 days

Sold 30.7% of holdings

Share of holding sold: 30.7%

Teva Pharmaceutical Industries trades, last 26 weeks

What else happened in Teva Pharmaceutical Industries around then

Filed or reported within 30 days of the trade day · 25/10/21~25/12/20

Christine Fox's recent trades

Christine FoxEVP, U.S. Commercial
SellTeva Pharmaceutical Industries
Sell
Teva Pharmaceutical Industries
TEVA
$750.6K
21,258 sh
$750.6K
Filed 05/04
Traded 04/30
Christine FoxEVP, U.S. Commercial
Planned saleTeva Pharmaceutical Industries
Planned sale
Teva Pharmaceutical Industries
TEVA
$750.6K
21,258 sh
$750.6K
Filed 04/30
Traded 04/30
Christine FoxEVP, U.S. Commercial
Sell10b5-1 planTeva Pharmaceutical Industries
Sell10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$251K
7,924 sh
$251K
Filed 03/09
Traded 03/05
Christine FoxEVP, U.S. Commercial
Sell10b5-1 planTeva Pharmaceutical Industries
Sell10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$295.3K
9,098 sh
$295.3K
Filed 03/06
Traded 03/04
Christine FoxEVP, U.S. Commercial
Planned sale10b5-1 planTeva Pharmaceutical Industries
Planned sale10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$250.9K
7,924 sh
$250.9K
Filed 03/05
Traded 03/05